• 1
    Avorn J, Soumerai S. Improving drug-therapy decisions through education outreach: a randomized, controlled trial of academically based “detailing.” N Engl J Med. 1983;308:1457–63.
  • 2
    Schaffner W, Ray WA, Federspiel CF. Improving antibiotic prescribing in office practice: a controlled trial of three education methods. JAMA. 1983 ; 250: 172832.
  • 3
    Ray WA, Fink R, Schaffner W, Federspiel CF. Improving antibiotic prescribing in outpatient practice: non-association of outcome with prescriber characteristics and measures of receptivity. Med Care. 1985 ; 23: 130713.
  • 4
    West SK, Brandon BM, Stevens AM, et al. Drug utilization review in an HMO, I: introduction and examples of methodology. Med Care. 1977 ; 15: 50514.
  • 5
    Hersey CO, Porter DK, Breslau D, Cohen DI. Influence of simple computerized feedback on prescription changes in an ambulatory clinic: a randomized, clinical trial. Med Care. 1986 ; 24: 47281.
  • 6
    Gehlback SH, Wilkinson WE, Hammond WE, et al. Improving drug prescribing in a primary care practice. Med Care. 1984 ; 22: 193201.
  • 7
    Groves R. Therapeutic drug-use review for the Florida Medicaid program. Am J Hosp Pharm. 1985 ; 42: 3169.
  • 8
    Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 1993 ; 153: 15483.
  • 9
    Dahlof B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish trial in old patients with hypertension (STOP-Hypertension). Lancet. 1991 ; 338: 12815.
  • 10
    Maniolio TA, Cutler JA, Furberg CD, Psaty BM, Whelton PK, Applegate WB. Trends in the pharmacologic management of hypertension in the United States. Arch Intern Med. 1995 ; 155: 82937.
  • 11
    Psaty BM, Heckber SR, Koepsell TD, et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA. 1995 ; 274(11):6205.
  • 12
    Furberg CD, Psaty BM, Meyer JV. Nifedipine: dose-related increase in mortality in patients with coronary heart disease. Circulation. 1995 ; 92(11):132631.
  • 13
    Borhani NO, Mercuri M, Borhani PA, et al. Final outcome results of the multicenter isradipine diuretic atherosclerosis study (MIDAS). JAMA. 1996 ; 276(11):78591.
  • 14
    Reiber GE, McDonnell MB, Schleyer AM, et al. A comprehensive system for quality improvement in ambulatory care: assessing quality of diabetes care. Patient Educ Couns. 1995 ; 26: 33741.
  • 15
    Noreen EW. Computer Intensive Methods for Testing Hypotheses. New York, NY: John Wiley & Sons; 1989.
  • 16
    Hilleman DE, Mohiuddin SM, Lucas BD, et al. Cost-minimization analysis of initial antihypertensive therapy in patients with mild-to-moderate essential diastolic hypertension. Clin Ther. 1994 ; 16(11):88102.
  • 17
    Neaton JD, Grimm RH, Prineas RJ, et al. Treatment of mild hypertension: final results. JAMA. 1993 ; 270(11):71324.
  • 18
    Boissel JP, Collet JP, Leon L, et al. A randomized comparison of the effect of four antihypertensive monotherapies on the subjective quality of life in previously untreated asymptomatic patients: field trial in general practice. J Hypertens. 1995 ; 13: 105967.